Evidence map›Paper›PMID 40076963›Full record

ArticleInternational journal of molecular sciences2025

Resveratrol Upregulates Antioxidant Factors Expression and Downmodulates Interferon-Inducible Antiviral Factors in Aging.

Iara Grigoletto Fernandes, Luana de M Oliveira, Milena M de Souza Andrade, Ricardo W Alberca, Júlia Cataldo Lima, Emanuella Sarmento Alho de Sousa, Anna Julia Pietrobon, Nátalli Zanete Pereira, Anna Cláudia Calvielli Castelo Branco, Alberto José da Silva Duarte and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Iara Grigoletto FernandesLaboratory of Dermatology and Immunodeficiencies, LIM-56, Tropical Medicine Institute of Sao Paulo, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 05508-000, Brazil.
Luana de M OliveiraLaboratory of Dermatology and Immunodeficiencies, LIM-56, Tropical Medicine Institute of Sao Paulo, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 05508-000, Brazil.ORCID 0000-0002-5546-1977
Milena M de Souza AndradeLaboratory of Dermatology and Immunodeficiencies, LIM-56, Tropical Medicine Institute of Sao Paulo, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 05508-000, Brazil.ORCID 0000-0003-0226-3413
Ricardo W AlbercaLaboratory of Dermatology and Immunodeficiencies, LIM-56, Tropical Medicine Institute of Sao Paulo, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 05508-000, Brazil.ORCID 0000-0002-3602-3306
Júlia Cataldo LimaLaboratory of Dermatology and Immunodeficiencies, LIM-56, Tropical Medicine Institute of Sao Paulo, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 05508-000, Brazil.
Emanuella Sarmento Alho de SousaLaboratory of Dermatology and Immunodeficiencies, LIM-56, Tropical Medicine Institute of Sao Paulo, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 05508-000, Brazil.ORCID 0000-0001-8861-635X
Anna Julia PietrobonLaboratory of Dermatology and Immunodeficiencies, LIM-56, Tropical Medicine Institute of Sao Paulo, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 05508-000, Brazil.
Nátalli Zanete PereiraLaboratory of Dermatology and Immunodeficiencies, LIM-56, Tropical Medicine Institute of Sao Paulo, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 05508-000, Brazil.
Anna Cláudia Calvielli Castelo BrancoLaboratory of Dermatology and Immunodeficiencies, LIM-56, Tropical Medicine Institute of Sao Paulo, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 05508-000, Brazil.ORCID 0000-0001-7861-6890
Alberto José da Silva DuarteLaboratory of Dermatology and Immunodeficiencies, LIM-56, Tropical Medicine Institute of Sao Paulo, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 05508-000, Brazil.
Maria Notomi SatoLaboratory of Dermatology and Immunodeficiencies, LIM-56, Tropical Medicine Institute of Sao Paulo, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 05508-000, Brazil.ORCID 0000-0002-7911-1824

Funding

Foundation Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES) 88887.503842/2020-00Sao Paulo State Research Support Foundation FAPESP/n. 2019/02679-7, n. 2018/18230-6, n. 2020/13148-0, and n. 2020/15323-3
6 · The paper itself

Abstract

Immunosenescence, a process with a dysfunctional immune response that may favor infection is associated with an increase in inflammatory responses mediated by proinflammatory cytokines, characteristic of inflammaging. Aging and immunosenescence have a relationship relating to oxidative stress and inflammaging. Therefore, natural antioxidant compounds could be candidates for the control of the oxidative process. Our purpose was to evaluate the effect of resveratrol (Resv) on the antioxidant, antiviral, and anti-inflammatory responses induced by toll-like receptors (TLRs) 3, 4, and 7/8 agonists stimulation on peripheral blood mononuclear cells (PBMCs) of elderly and healthy female individuals (63-82 years old) and young and healthy female individuals (21-31 years old). Our data show that Resv may upregulate antioxidant factor expression, such as catalase (CAT) and SIRT1, in response to TLR4 and TLR7/8 agonists, similarly in both young and aged groups. Moreover, the Resv anti-inflammatory effect was detected by inhibiting IL-1β, TNF-α, and IL-10 secretion levels, as well as by the chemokines CCL2 and CCL5, induced by TLR4 and TLR7/8 stimulation. Curiously, Resv decreased antiviral genes, such as MxA, STING, and IRF7 expression, possibly by reducing the inflammatory effects of interferon-induced genes. Taken together, our results demonstrate the ability of Resv to stimulate antioxidant factors, leading to a downmodulation of the inflammatory response induced by innate immune stimulation. These findings point out Resv as a strategy to control the upregulation of inflammatory response, even in elderly individuals.

Indexed as

AgingAntioxidantsInterferonsResveratrolAdultAgedAged, 80 and overCatalaseCytokinesFemaleHumansLeukocytes, MononuclearMiddle AgedOxidative StressSirtuin 1Toll-Like ReceptorsAntioxidantsCatalaseCytokinesInterferonsResveratrolSirtuin 1Toll-Like Receptorsagingantioxidantantiviralinflammaginginnate immunityresveratroltoll-like receptors

Identifiers

PMID40076963
PMCPMC11900160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.